Cardiac troponin I in congenital heart defects with pressure or volume overload

Anneli Eerola1, Eero O Jokinen, Tanja I Savukoski

  • 1Department of Pediatrics, Tampere University Hospital, Tampere, Finland. anneli.eerola@fi mnet.fi

Insights

Cardiac troponin I (cTnI) release is more common in children with pressure overload congenital heart defects than volume overload. This cardiac biomarker elevation typically resolves after treatment.

Area of Science:

  • Pediatric Cardiology
  • Biomarkers in Congenital Heart Disease

Background:

  • Congenital heart defects (CHDs) can lead to volume or pressure overload.
  • Cardiac troponin I (cTnI) is a marker of myocardial injury.
  • Autoantibodies to cTn may play a role in cardiac conditions.

Purpose of the Study:

  • To determine the prevalence of cTnI and anti-cTn autoantibodies in children with CHDs causing overload.
  • To compare cTnI levels in children with pressure overload versus volume overload CHDs.
  • To assess changes in cTnI after treatment for CHDs.

Main Methods:

  • Study included 78 children with volume overload CHDs, 60 with pressure overload CHDs, and 74 healthy controls.
  • Serum levels of natriuretic peptides, cTnI, and anti-cTn autoantibodies were measured at baseline and 6 months post-treatment.
  • Analysis compared baseline characteristics and outcomes between groups.

Main Results:

  • Baseline cTnI was positive in 1 child (volume overload), 12 children (pressure overload), and 1 control.
  • Children with positive cTnI and pressure overload were younger, had higher natriuretic peptides, and greater pressure gradients.
  • Post-treatment, 63 of 64 children showed negative cTnI levels.

Conclusions:

  • Pressure overload in CHDs is more strongly associated with cTnI release than volume overload.
  • cTnI elevation in these pediatric patients is generally transient and resolves post-intervention.
  • cTnI may serve as a useful biomarker for assessing the impact of pressure overload in CHDs.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...